Chemical Structure (Duloxetine 01)
Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 72162-1598
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 72162-1598). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Duloxetine 02)
Not available.*
Figure 2 (Duloxetine 03)
Figure 3 (Duloxetine 04)
Figure 4 (Duloxetine 05)
Figure 5 (Duloxetine 06)
Figure 6 (Duloxetine 07)
Figure 7 (Duloxetine 08)
Figure 8 (Duloxetine 09)
Figure 9 (Duloxetine 10)
Figure 10 (Duloxetine 11)
Label (Lbl721621598)
This is a description for Duloxetine Hydrochloride, an active ingredient found in each capsule of DULoxetine Delayed-Release Capsules, USP. Each capsule contains 33.7 mg of the ingredient, which is equivalent to 30 mg of Duloxetine. This medication should be kept out of reach of children and stored at a temperature between 25°C to 30°C (77°F to 86°F). It should be dispensed in a tightly closed container and should be accompanied by a medication guide for each patient. For more information, please visit the FDA website at https://www.accessdata.fda.gov/scripts/cde. Unfortunately, no additional information is provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
